Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs
- 30 September 2010
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 136 (3), 348-363
- https://doi.org/10.1016/j.clim.2010.04.018
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Inhibition of HDAC9 Increases T Regulatory Cell Function and Prevents Colitis in MiceGastroenterology, 2010
- Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cellsNature Reviews Drug Discovery, 2009
- Epigenetic control of skull morphogenesis by histone deacetylase 8Genes & Development, 2009
- Molecular orchestration of differentiation and function of regulatory T cellsGenes & Development, 2009
- Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the MorningImmunity, 2009
- Foxp3 Processing by Proprotein Convertases and Control of Regulatory T Cell FunctionJournal of Biological Chemistry, 2009
- The many roles of histone deacetylases in development and physiology: implications for disease and therapyNature Reviews Genetics, 2009
- Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryosDevelopmental Biology, 2008
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and menNature Reviews Molecular Cell Biology, 2008
- FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repressionProceedings of the National Academy of Sciences of the United States of America, 2007